Oxford Nanopore and UK Biobank to create world’s largest epigenetic dataset
LONDON: Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK...
Artios collaborates with Novartis to create next generation DDR cancer therapies
LONDON: Arix Bioscience’s portfolio company Artios Pharma Limited announced a global research collaboration with Novartis to discover and validate next generation DDR targets to enhance...